Estimating the Effect of COVID-19 Pandemic Restrictions on Self-reported Antiretroviral Therapy Use and Late Refill Visits Among People Living With HIV in Rural South Africa.

Journal: Journal of acquired immune deficiency syndromes (1999)

Volume: 96

Issue: 4

Year of Publication: 2024

Affiliated Institutions:  Department of Epidemiology, University of Washington, Seattle, WA. Department of Biostatistics, University of Washington, Seattle, WA. Center for Community Based Research, Human Sciences Research Council, Sweetwaters, Pietermaritzburg, South Africa. Department of Global Health, University of Washington, Seattle, WA. Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA; and.

Abstract summary 

People living with HIV require reliable access to and adequate supply of antiretroviral therapy (ART) for viral suppression. The Deliver Health Study, a randomized trial conducted during the COVID-19 pandemic, found that home-delivered ART significantly increased viral suppression compared with clinic-based care. The effect of changing COVID-19 alert levels on self-reported ART use has not been quantified.KwaZulu-Natal, South Africa.Adults living with HIV were followed in the Deliver Health Study during October 2019-December 2020. We used difference-in-differences (DiD) to estimate the effect of changing COVID-19 alert levels during 3 distinct periods on self-reported missed ART doses (missed 0 vs. ≥1 doses in past week) for participants receiving home-delivered vs. clinic-based refills. We additionally estimated the effect of changing COVID-19 alert levels on late clinic ART refill visits (late vs. on-time). We used relative risk regression for both binary outcomes.Of 155 participants, 46% were women and the median age was 36 years. The mean number of missed weekly doses was 0.11, 0, and 0.12 in the home-delivery group and 0.09, 0.08, and 0.18 in the clinic group during periods 1, 2, and 3, respectively. There were no differences in relative risk of self-reported daily ART use between refill groups when comparing across periods [DiDperiod 2 vs. 1 = 1.05; 95% confidence interval: 0.97, 1.13 and DiDperiod 3 vs. 2 = 0.99; 95% confidence interval (CI): 0.91, 1.08]. In the clinic group, the risk of late refill visits was significantly higher during COVID-19 restrictions (vs. before alert level 5 implementation) and even after the COVID-19 alert level was downgraded to level 1 (RRperiod 2 vs. 1 = 1.83, 95% CI: 1.34, 2.51 and RRperiod 3 vs. 2 = 1.71; 95% CI: 1.43, 2.04).The COVID-19 pandemic did not differentially impact self-reported ART adherence by the method of ART refills, but the risk of late clinic refill visits was significantly higher during COVID-19 restrictions and sustained after restrictions were loosened.

Authors & Co-authors:  Tseng Ashley S AS Mugwanya Kenneth K KK Szpiro Adam A AA van Heerden Alastair A Ntinga Xolani X Schaafsma Torin T TT Barnabas Ruanne V RV

Study Outcome 

Source Link: Visit source

Statistics
Citations :  UNAIDS. Global HIV & AIDS Statistics — Fact Sheet 2023.; 2023. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
Authors :  7
Identifiers
Doi : 10.1097/QAI.0000000000003431
SSN : 1944-7884
Study Population
Women
Mesh Terms
Humans
Other Terms
Study Design
Randomized Control Trial
Study Approach
Country of Study
South Africa
Publication Country
United States